The publisher regrets that one of the authors is missing in the PDF and web version of the article. Namely, Anton Bouter, who is affiliated with the Centrum Wiskunde & Informatica as described above in this erratum. In table 1, a space is missing after the character “<” in the line `Cervix -> Sigmoid' in column `Sparing criteria'. In table 3, the `%' signs in first column (DVI) should also be in subscript, similar to how it is written in the first column of Table 4. The supplementary material should state that needle contribution is limited to up to 40% of the total given dwell time (in applicator and needles). Lastly, the article should be seen as a research article and the authors would like to be cited as “L.R.M. Dickhoff and R.J. Scholman et al”.

The publisher would like to apologise for any inconvenience caused.@en

PURPOSE: Without a clear definition of an optimal treatment plan, no optimization model can be perfect. Therefore, instead of automatically finding a single “optimal” plan, finding multiple, yet different near-optimal plans, can be an insightful approach to support radiation oncologists in finding the plan they are looking for. METHODS AND MATERIALS: BRIGHT is a flexible AI-based optimization method for brachytherapy treatment planning that has already been shown capable of finding high-quality plans that trade-off target volume coverage and healthy tissue sparing. We leverage the flexibility of BRIGHT to find plans with similar dose-volume criteria, yet different dose distributions. We further describe extensions that facilitate fast plan adaptation should planning aims need to be adjusted, and straightforwardly allow incorporating hospital-specific aims besides standard protocols. RESULTS: Results are obtained for prostate (n = 12) and cervix brachytherapy (n = 36). We demonstrate the possible differences in dose distribution for optimized plans with equal dose-volume criteria. We furthermore demonstrate that adding hospital-specific aims enables adhering to hospital-specific practice while still being able to automatically create cervix plans that more often satisfy the EMBRACE-II protocol than clinical practice. Finally, we illustrate the feasibility of fast plan adaptation. CONCLUSIONS: Methods such as BRIGHT enable new ways to construct high-quality treatment plans for brachytherapy while offering new insights by making explicit the options one has. In particular, it becomes possible to present to radiation oncologists a manageable set of alternative plans that, from an optimization perspective are equally good, yet differ in terms of coverage-sparing trade-offs and shape of the dose distribution.

@en